1.Construction and characterization of Escherichia coli D-3-phosphoglycerate dehydrogenase mutants with feedback-inhibition relief.
Hui DENG ; Cunwu CHEN ; Chuanbo SUN ; Chuanbao WEI
Chinese Journal of Biotechnology 2016;32(4):468-477
3-Phosphoglycerate dehydrogenase (PGDH, EC 1.1.1.95) is the key enzyme in L-serine biosynthesis and its coding gene is serA. PGDH is feedback inhibited by L-serine. In order to relieve the feedback-inhibition of PGDH by L-serine, H344 or D346 or D364 were chosen for site directed mutagenesis. The mutants were generated by the standard QuikChange mutagenesis, further subcloned into expression vector pT7-7 and transformed into Escherichia coli BL21 (DE3) cells. The recombinant cells were collected after cultured in LB media post induced by isopropyl beta-Dthiogalactopyranoside. The enzymes were purified by anion exchange chromatography, and SDS-PAGE showed that the purified enzymes were homogenous. Enzyme characterization indicated that the mutant enzyme showed similar activity, optimal temperature, and optimal pH as that of the wild-type enzyme. Moreover, feedback inhibition study showed that the activity of the double mutant (N346A/H344A) could remain 96% in the presence of serine up to 160 mmol/L, whereas the activity of the wild-type enzyme remains only 50% in the presents of serine of 7 μmol/L, thus successfully relieving the feedback inhibition of PGDH with its activity remained.
Electrophoresis, Polyacrylamide Gel
;
Escherichia coli
;
enzymology
;
Escherichia coli Proteins
;
genetics
;
Industrial Microbiology
;
Mutagenesis, Site-Directed
;
Phosphoglycerate Dehydrogenase
;
genetics
;
Serine
;
biosynthesis
2.Genetic and phenotypic analysis of a patient with phosphogylcerate dehydrogenase deficiency.
Chinese Journal of Medical Genetics 2021;38(2):170-173
OBJECTIVE:
To explore the genetic basis for a child with ocular anomaly, microcephaly, growth retardation and intrauterine growth restriction.
METHODS:
The patient underwent ophthalmologic examinations including anterior segment photography, fundus color photography, and fundus fluorescein angiography. The patient and her parents were subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing and bioinformatic analysis.
RESULTS:
The patient was found to have bilateral persistent pupillary membrane and coloboma of inferior iris, in addition with macular dysplasia and radial pigmentation near the hemal arch of the temporal retina. She was found to have carried compound heterozygous missense variants of the PHGDH gene, namely c.196G>A and c.1177G>A, which were respectively inherited from her father and mother. Bioinformatic analysis suggested both variants to be pathogenic.
CONCLUSION
The patient was diagnosed with phosphoglycerate dehydrogenase deficiency. Above finding has enriched the phenotypic spectrum of the disease with ocular manifestations.
Carbohydrate Metabolism, Inborn Errors/genetics*
;
Child
;
Coloboma
;
Female
;
Humans
;
Microcephaly/genetics*
;
Mutation
;
Phenotype
;
Phosphoglycerate Dehydrogenase/genetics*
;
Psychomotor Disorders/genetics*
;
Seizures/genetics*
;
Whole Exome Sequencing
3.Gene Expression Profile of Lung Cancer Cells Following Photodynamic Therapy.
Ji Hyun SUNG ; Mi Eun LEE ; Seon Sook HAN ; Seung Joon LEE ; Kwon Soo HA ; Woo Jin KIM
Tuberculosis and Respiratory Diseases 2007;63(1):52-58
BACKGROUND: Photodynamic therapy is a viable option for lung cancer treatment, and many studies have shown that it is capable of inducing cell death in lung cancer cells. However, the precise mechanism of this cell death has not been fully elucidated. To investigate the early changes in cancer cell transcription, we treated A549 cells with the photosensitizer DH-I-180-3 and then we illuminated the cells. METHODS: We investigated the gene expression profiles of the the A549 lung cancer cell line, using a DEG kit, following photodynamic therapy and we evaluated the cell viability by performing flow cytometry. We identified the genes that were significantly changed following photodynamic therapy by performing DNA sequencing. RESULTS: The FACS data showed that the cell death of the lung cancer cells was mainly caused by necrosis. We found nine genes that were significantly changed and we identified eight of these genes. We evaluated the expression of two genes, 3-phosphoglycerate dehydrogenase and ribosomal protein S29. The expressed level of carbonic anhydrase XII, clusterin, MRP3s1 protein, complement 3, membrane cofactor protein and integrin beta 1 were decreased. CONCLUSION: Many of the gene products are membrane-associated proteins. The main mechanism of photodynamic therapy with using the photosensitizing agent DH-I-180-3 appears to be necrosis and this may be associated with the altered production of membrane proteins.
Antigens, CD46
;
Carbonic Anhydrases
;
Cell Death
;
Cell Line
;
Cell Survival
;
Clusterin
;
Complement System Proteins
;
Flow Cytometry
;
Gene Expression Profiling
;
Gene Expression*
;
Lung Neoplasms*
;
Lung*
;
Membrane Proteins
;
Necrosis
;
Phosphoglycerate Dehydrogenase
;
Photochemotherapy*
;
Photosensitizing Agents
;
Ribosomal Proteins
;
Sequence Analysis, DNA
;
Transcriptome*
4.Cloning and expression of 3-phosphoglycerate dehydrogenase gene and its correlative antibodies in diagnosis of autoimmune hepatitis.
Dai-jun XIANG ; Hui-ping YAN ; Qing XIA ; Feng LU ; Xia FENG ; Yan ZHAO ; Yan LIU ; Jian-xuan YANG
Chinese Journal of Hepatology 2009;17(5):378-382
OBJECTIVETo evaluate whether the D-3-phosphoglycerate dehydrogenase (Phgdh) correlative antibodies is crucial for AIH, we cloned Phgdh cDNA and constructed plasmid, then purified and identified the immunoreactivity of the recombinant protein, and established the enzyme linked immunosorbent assay (ELISA) to detect Phgdh autoantigen correlative antibodies in diagnosis of autoimmune hepatitis.
METHODSThe constructed plasmid was transformed into E. coli. BL21(D3). This fusion protein was purified by Ni-NTA chromatography and its immunoreactivity was identified by SDS-PAGE and Western blot. The ELISA with the fusion protein was established first, then, the Phgdh autoantigen correlative antibodies in serum of patients with AIH (65) and patients with PBC (122) as well as chronic hepatitis B (CHB) (56), chronic hepatitis C (CHC) (117), and normal controls (60) were detected.
RESULTSThe sequence of Phgdh autoantigen gene was the same as the sequence reported on the genebank. The fusion protein was found about 60kD strip on SDS-PAGE. Western blot analysis showed that the fusion protein had immunoreactivity. When analyzing the serum by ELISA, the immune reactivity to Phgdh was detected in 66.15% of patients with AIH, 21.42% of patients with PBC, 12.50% of patients with CHB, 6.83% of patients with CHC, and 3.30% of normal individuals. The differences of prevalence between AIH patients and healthy controls as well as other diseases were of statistical significance (P less than 0.01).
CONCLUSIONThe Phgdh cDNA is successfully cloned into E. coli BL21 (D3). The frequency of antibodies to Phgdh is much higher in patients with AIH than in patients with PBC, CHB, CHC and normal control. The antibodies to Phgdh may have utility in improved diagnosis of AIH.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Autoantibodies ; analysis ; genetics ; Autoantigens ; immunology ; Cloning, Molecular ; Enzyme-Linked Immunosorbent Assay ; methods ; Escherichia coli ; genetics ; metabolism ; Female ; Gene Expression ; Genetic Vectors ; Hepatitis B, Chronic ; blood ; diagnosis ; Hepatitis, Autoimmune ; blood ; diagnosis ; Humans ; Liver Cirrhosis, Biliary ; blood ; diagnosis ; Male ; Middle Aged ; Phosphoglycerate Dehydrogenase ; genetics ; immunology ; Plasmids ; Recombinant Proteins ; genetics ; metabolism ; Young Adult